info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » pharmaceuticals

pharmaceuticals

Anorexiants Market By Drug Type (Stimulant-Based, Non-Stimulant-Based); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Anorexiants Market is projected to grow at a CAGR of 6.1%, reaching USD 5.6 billion by 2030, up from an estimated USD 3.9 billion in 2024, according to Strategic Market Research.

 

... Read More

Published Date: SEP-2025 | No Of Pages:174 | $ 4485

Sulphonamides Market By Product Type (Oral, Topical, Injectable); By Application (Urinary Tract Infections, Respiratory Infections, Gastrointestinal Infections, Dermatological Infections); By End User (Hospitals, Clinics, Pharmacies, Outpatient Care Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Sulphonamides Market is poised to experience steady growth in the coming years, driven by increasing applications in both human and veterinary medicine, as well as advancements in drug formulations. In Read More

Published Date: SEP-2025 | No Of Pages:178 | $ 4485

Raloxifene Hydrochloride Market by Product Type (Oral Tablets, Injectable Forms); By End User (Hospitals, Outpatient Care Centers, Diagnostic Centers, Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Raloxifene Hydrochloride Market is projected to experience steady growth, with an estimated market value of USD 3.2 billion in 2024. This is expected t... Read More

Published Date: SEP-2025 | No Of Pages:185 | $ 4485

Proteasome Inhibitors Market By Drug Class (Carfilzomib, Bortezomib, Ixazomib); By Application (Oncology, Neurodegenerative Diseases, Autoimmune Disorders); By End User (Hospitals, Specialized Cancer Clinics, Diagnostic Imaging Centers, Research Institutes); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global Proteasome Inhibitors Market is expected to witness a significant expansion, projected to grow from USD 17.8 billion in 2024 to USD 34.6 billion by 2030Read More

Published Date: SEP-2025 | No Of Pages:176 | $ 4485

Phosphodiesterase Inhibitors Market By Drug Type (PDE5 Inhibitors, PDE4 Inhibitors, PDE3 Inhibitors); By Application (Cardiovascular Disorders, Erectile Dysfunction, Respiratory Disorders, Neurological Disorders); By End User (Hospitals, Clinics, Specialized Pharmacies, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Phosphodiesterase Inhibitors Market will witness a steady growth trajectory, with a projected compound annual growth rate (CAGR) of 6.5%, valued at USD 3.2 billion in 2024Read More

Published Date: SEP-2025 | No Of Pages:186 | $ 4485

Montelukast Sodium Market By Product Type (Tablets, Chewable Tablets, Granules); By Application (Asthma, Allergic Rhinitis, Others); By End User (Hospitals, Clinics, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global Montelukast Sodium Market is positioned for notable growth between 2024 and 2030 , with a projected market size of USD 5.6 billion by 2030Read More

Published Date: SEP-2025 | No Of Pages:174 | $ 4485

Effervescent Tablet Market By Product Type (Prescription-Based, Over-the-Counter); By Application (Vitamins & Minerals, Pain Relief, Digestive Health, Cold & Flu, Others); By Distribution Channel (Pharmacies, Supermarkets & Health Stores, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Effervescent Tablet Market is projected to grow at a CAGR of 7.8% , starting from an estimated USD 4.6 billion in 2024 and reaching USD 7.2 billion by 2030Read More

Published Date: SEP-2025 | No Of Pages:182 | $ 4485

Diuretics Drugs Market By Drug Class (Thiazide Diuretics, Loop Diuretics, Potassium-Sparing Diuretics, Others); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Diuretics Drugs Market will witness a moderate yet resilient CAGR of 4.9% , valued at USD 13.7 billion in 2024 , and expected to reach... Read More

Published Date: SEP-2025 | No Of Pages:172 | $ 4485

Chronic Fatigue Syndrome (CFS) Treatment Market By Treatment Type (Pharmacological, Non-Pharmacological, Nutritional & Supplement-Based); By End-User (Hospitals, General Practitioners, Outpatient Care Providers, Home Healthcare); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global Chronic Fatigue Syndrome ( CFS ) Treatment Market is projected to experience steady growth, with a compound annual growth rate (CAGR) ... Read More

Published Date: SEP-2025 | No Of Pages:174 | $ 4485

Binders Excipients Market By Source (Natural Binders, Synthetic Binders); By Form (Dry Binders, Liquid Binders); By Drug Release Type (Immediate-Release, Controlled-Release); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Binders Excipients Market is projected to grow at a CAGR of 5.8% between 2024 and 2030. Valued at USD 1.27 billion in 2024, the market is on track to reach USD 1.78 billion by 2030, according to Strateg... Read More

Published Date: SEP-2025 | No Of Pages:161 | $ 4485

Beta-lactam and Beta-lactamase Inhibitors Market By Drug Class (Penicillins, Cephalosporins, Carbapenems, Monobactams, Beta-lactamase Inhibitor Combinations); By Route of Administration (Oral, Parenteral); By Infection Type (Respiratory, Urinary Tract, Skin, Bloodstream, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Beta-Lactam And Beta-Lactamase Inhibitors Market is poised to grow steadily, expanding from USD 27.8 billion in 2024 to an estimated <... Read More

Published Date: SEP-2025 | No Of Pages:184 | $ 4485

Antidepressant Drugs Market By Drug Type (SSRIs, SNRIs, TCAs, MAOIs, Atypical Antidepressants); By Route of Administration (Oral, Injectable); By End User (Hospitals, Clinics, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Antidepressant Drugs Market is expected to grow at a steady pace, with a projected CAGR of 6.4% from 2024 to 2030 , reaching an estimated market value ... Read More

Published Date: SEP-2025 | No Of Pages:192 | $ 4485

Anaplastic Thyroid Cancer Drugs Market By Drug Type (Chemotherapy, Targeted Therapies, Immunotherapy); By Route of Administration (Oral, Intravenous); By End User (Hospitals, Specialty Clinics, Diagnostic Imaging Centers, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Anaplastic Thyroid Cancer Drugs Market is projected to witness substantial growth in the coming years. The market, valued at USD 1.5 billion in 2024, is anticipated to reach USD 3.2 bi... Read More

Published Date: SEP-2025 | No Of Pages:195 | $ 4485

Amlodipine Besylate Market By Product Type (Standalone Amlodipine, Fixed-Dose Combinations); By Route of Administration (Oral Tablet, Orally Disintegrating Tablet); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Amlodipine Besylate Market is projected to grow at a CAGR of 4.9%, reaching around 2.87 billion dollars by 2030 , up ... Read More

Published Date: SEP-2025 | No Of Pages:171 | $ 4485

Simethicone Market By Product Type (Tablets and Capsules, Suspensions and Liquids, Chewables and Others); By Application (Gastrointestinal Disorders, Pediatric Care, Others); By End User (Pharmacies and Drug Stores, Hospitals and Clinics, Online Retail, Diagnostic and Wellness Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global Simethicone Market is expected to experience steady growth, driven by increasing consumer demand for over-the-counter (OTC) anti-gas products. Valued at USD 1.6 billion... Read More

Published Date: SEP-2025 | No Of Pages:199 | $ 4485

Mono Vaccine Market By Vaccine Type (Live Attenuated, Inactivated, Subunit, Recombinant, Conjugate, Toxoid); By Disease Target (Infectious Diseases, Cancer, Other Diseases); By End-User (Government Programs, Private Healthcare Providers, NGOs, Distributors, Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global Mono Vaccine Market is anticipated to experience a steady growth rate, projected to expand from USD 18.5 billion in 2024 to USD 27.4 billionRead More

Published Date: SEP-2025 | No Of Pages:185 | $ 4485

Antithrombotic Drugs Market By Drug Class (Anticoagulants, Antiplatelet Agents, Thrombolytics); By Route of Administration (Oral, Parenteral); By Indication (Atrial Fibrillation, Deep Vein Thrombosis/Pulmonary Embolism, Stroke, Acute Coronary Syndrome, Peripheral Artery Disease); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Antithrombotic Drugs Market is poised to expand at a CAGR of 6.4% , reaching an estimated USD 54.8 billion by 2030 , up from USD 37.7 billion i... Read More

Published Date: SEP-2025 | No Of Pages:187 | $ 4485

X-ray Diffractometer Market By Type (Powder XRD, Single-Crystal XRD, Benchtop XRD); By Application (Pharmaceuticals, Electronics & Semiconductors, Energy & Battery Materials, Metallurgy & Ceramics); By End User (Academic & Research Institutions, Industrial & Manufacturing, Pharmaceutical Companies, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global X -Ray Diffractometer Market is poised to grow steadily, projected to reach USD 2.3 billion by 2030 , up from an estimated USD 1.5 billion in 2... Read More

Published Date: SEP-2025 | No Of Pages:186 | $ 4485

Vertigo Treatment Market By Treatment Type (Drugs, Vestibular Rehabilitation Therapy, Surgical/Device-Based Treatment); By Disorder Type (BPPV, Vestibular Migraine, Meniere’s Disease, Vestibular Neuritis); By Route of Administration (Oral, Injectable, Transdermal, Intranasal); By End User (Hospitals, ENT Clinics, Rehabilitation Centers, Digital Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Vertigo Treatment Market is projected to grow steadily, with an estimated value of USD 3.8 billion in 2024 , reaching approximately USDRead More

Published Date: SEP-2025 | No Of Pages:199 | $ 4485

Transdermal Drug Delivery System Market By Product Type (Transdermal Patches, Gels & Creams, Microneedle Patches, Iontophoretic Devices); By Application (Pain Management, Hormonal Therapy, CNS Disorders, Cardiovascular Diseases, Smoking Cessation); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Transdermal Drug Delivery System Market will witness a steady CAGR of 6.8% , valued at USD 8.9 billion in 2024 , and projected to reach USD 13.3 billion by 2030... Read More

Published Date: SEP-2025 | No Of Pages:162 | $ 4485

Immunotherapy Drugs Market By Therapy Type (Monoclonal Antibodies, Checkpoint Inhibitors, CAR T-cell Therapy, Vaccines, Biosimilars); By Application (Oncology, Autoimmune Diseases, Infectious Diseases, Others); By End User (Hospitals, Specialty Clinics, Research Institutions, Pharmaceutical Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Immunotherapy Drugs Market will witness a notable CAGR of 12.4% , valued at USD 132.5 billion in 2024 , and projected to reach Read More

Published Date: SEP-2025 | No Of Pages:160 | $ 4485

Gastroparesis Drugs Market By Drug Class (Prokinetic Agents, Antiemetics, Ghrelin Agonists, Tricyclic Antidepressants, Others); By Route of Administration (Oral, Injectable, Transdermal/Sublingual); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Gastroparesis Drugs Market is projected to grow at a CAGR of 6.8 % from 2024 to 2030. Valued at approximately USD 7.1... Read More

Published Date: SEP-2025 | No Of Pages:173 | $ 4485

Antibacterial Drugs Market By Drug Class (Beta-Lactams, Quinolones, Macrolides, Tetracyclines, Aminoglycosides, Others); By Route of Administration (Oral, Parenteral, Topical); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Antibacterial Drugs Market is poised for stable, value-driven expansion, with a valuation of USD 43.7 billion in 2024 , and is projected to reach USD 56.4 billion by 2030Read More

Published Date: SEP-2025 | No Of Pages:175 | $ 4485

Hinokitiol Market By Application (Cosmeceuticals & Skincare, Pharmaceuticals, Oral Care, Nutraceuticals); By Form Type (Pure Hinokitiol, Extract Blends, Synthetic Variants); By End User (Cosmetic Brands, Pharma R&D, Dental Product Manufacturers, Spa/Wellness Brands); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Hinokitiol Market is projected to grow at a CAGR of 6.8% , with an estimated value of USD 412 million in 2024 , expected to reach arou... Read More

Published Date: SEP-2025 | No Of Pages:196 | $ 4485

Tadalafil Market By Product Type (Branded Tadalafil, Generic Tadalafil); By Application (Erectile Dysfunction, Benign Prostatic Hyperplasia, Pulmonary Arterial Hypertension, Off-Label Uses); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online/Telehealth); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Tadalafil Market is projected to reach a valuation of $6.4 billion by 2030 , growing from an estimated $4.1 billion in 2024 , registering a steady CAGR of 7.7%<... Read More

Published Date: SEP-2025 | No Of Pages:163 | $ 4485

Nanoparticle Drug Delivery Systems Market By Drug Type (Chemotherapy Drugs, Gene Therapy Drugs, Protein and Peptide Drugs); By Technology Type (Liposomes, Polymeric Nanoparticles, Solid Lipid Nanoparticles); By Application (Cancer Treatment, Neurological Disorders, Infectious Diseases); By End User (Children’s Hospitals, General Hospitals, Research Institutions, Pharmaceutical Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global Nanoparticle Drug Delivery Systems Market is poised for substantial growth, valued at USD 4.2 billion in 2024 and expected to reach USD 8.6 billion by ... Read More

Published Date: SEP-2025 | No Of Pages:168 | $ 4485

Musculoskeletal Disorders Drugs Market By Drug Class (NSAIDs, Corticosteroids, DMARDs, JAK Inhibitors, Bone Agents, Opioids, Others); By Indication (Osteoarthritis, Rheumatoid Arthritis, Osteoporosis, Ankylosing Spondylitis, Back Pain, Gout, Others); By Route of Administration (Oral, Injectable, Topical, Transdermal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global Musculoskeletal Disorders Drugs Market will witness a steady CAGR of 6.1% , valued at USD 69.2 billion in 2024 , and expected to reach USD 104.3 billion by 2030... Read More

Published Date: SEP-2025 | No Of Pages:194 | $ 4485

Menstrual Drugs Market By Product Type (NSAIDs, Hormonal Therapies, Antifibrinolytics, Botanical Supplements, Others); By Route of Administration (Oral, Injectable, Topical); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Menstrual Drugs Market will witness a steady CAGR of 6.9% , valued at approximately USD 5.8 billion in 2024 , and projected to reach USD 8.7 bi... Read More

Published Date: SEP-2025 | No Of Pages:163 | $ 4485

Longevity and Anti-Senescence Therapy Market By Therapy Type (Gene Therapy, Senolytic Therapy, Cellular Rejuvenation, Anti-Aging Pharmaceuticals); By Application (Neurodegenerative Diseases, Cardiovascular Diseases, Osteoporosis, Skin and Aesthetic Applications, Metabolic Disorders); By End User (Healthcare Providers, Biotechnology Companies, Consumers, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Longevity and Anti-Senescence Therapy Market is poised for robust growth, with a compound annual growth rate (CAGR) of 12.8% , valued at USD 5.3 billion in 2024 , and expected... Read More

Published Date: SEP-2025 | No Of Pages:166 | $ 4485

Blood Plasma Derivatives Market By Product Type (Immunoglobulins, Albumin, Clotting Factor Concentrates, Other Plasma Derivatives); By Application (Immunology, Hematology, Neurology, Other Applications); By End User (Hospitals, Blood Banks, Pharmaceutical Manufacturers, Diagnostic Centers, Clinics & ASCs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Blood Plasma Derivatives Market is poised to experience a robust growth trajectory, with a CAGR of 7.4% from 2024 to 2030. This market, valued at approximately ... Read More

Published Date: AUG-2025 | No Of Pages:179 | $ 4485

Progressive Supranuclear Palsy Market by Treatment Type (Drug Therapy, Physical Therapy, Surgical Interventions); By End User (Hospitals, Ambulatory Surgical Centers, Research Institutions, Diagnostic Imaging Centers); By Diagnostic Method (MRI and CT Scans, Genetic Testing, Biomarker Detection); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Progressive Supranuclear Palsy M arket will experience a steady growth trajectory with a projected CAGR of approximately 5.2% from 2024 to 2030. PSP, a rare a... Read More

Published Date: AUG-2025 | No Of Pages:180 | $ 4485

Pediatric Epilepsy Therapeutics Market By Drug Type (Anti-Epileptic Drugs, Gene Therapy, Neurostimulation Devices, Ketogenic Diet); By Treatment Modality (Pharmacological Treatment, Surgical Treatment, Neurostimulation); By End User (Childrens Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Pediatric Epilepsy Therapeutics Market is on track to experience significant growth, with an expected CAGR of 6.5% , valued at approximately USD 5.2 billion in 2024 , and projected to reach USD 8.7 billion by 2030 , confirms S... Read More

Published Date: AUG-2025 | No Of Pages:162 | $ 4485

Epidermolysis Bullosa (EB) Treatment Market By Treatment Type (Gene Therapy, Stem Cell Therapy, Topical Therapies, Enzyme Replacement Therapy); By Therapeutic Approach (Gene Editing, Symptomatic Treatment, Combination Therapies); By End User (Children’s Hospitals, General Hospitals, Diagnostic Clinics, Home Healthcare Providers); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global Epidermolysis Bullosa Treatment Market is expected to grow at a robust compound annual growth rate (CAGR) of 8.5% , with the market valued at approximately USD ... Read More

Published Date: AUG-2025 | No Of Pages:189 | $ 4485

Endocrinology Drugs Market By Product Type (Insulin Therapies, Thyroid Hormone Replacement, Corticosteroids, Other Hormone Replacement Drugs); By Application (Diabetes, Thyroid Disorders, Adrenal Disorders, Other Endocrine Disorders); By End User (Hospitals, Specialty Clinics, Retail Pharmacies, Diagnostic Imaging Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Endocrinology Drugs Market is poised for considerable growth, driven by an increasing prevalence of endocrine-related diseases such as diabetes, thyroid disorders, and adrenal insufficiencies. Valued at Read More

Published Date: AUG-2025 | No Of Pages:172 | $ 4485

Antidiuretic Drugs Market By Product Type (Desmopressin, Vasopressin, Others); By Indication (Diabetes Insipidus, SIADH); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global Antidiuretic Drugs Market will experience significant growth, with a CAGR of 6.5% , projected to reach USD 7.3 billion by 2030 from USD 4.2 bil... Read More

Published Date: AUG-2025 | No Of Pages:200 | $ 4485

Generic Drugs Market By Drug Type (Prescription Generics, OTC Generics); By Therapeutic Area (Cardiovascular, Oncology, Diabetes, Infectious Diseases, Others); By Market Type (Branded Generics, Non-branded Generics); By Region, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Generic Drugs Market is anticipated to experience substantial growth, projected to expand at a CAGR of approximately 6.8% from 2024 to 2030 , with an e... Read More

Published Date: AUG-2025 | No Of Pages:177 | $ 4485

Legal Cannabis Market By Product Type (Flower, Concentrates, Edibles & Beverages, Topicals & Tinctures); By Application (Medical Use, Recreational Use); By Compound Type (THC-Dominant, CBD-Dominant, Balanced); By Distribution Channel (Dispensaries, Pharmacies, Online, Wellness Retailers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Legal Cannabis Market is projected to expand at a CAGR of 13.6% , valued at USD 42.3 billion in 2024 and expected to reach around USD 102.1 bil... Read More

Published Date: AUG-2025 | No Of Pages:186 | $ 4485

Cleanroom Consumables Market By Product Type (Cleanroom Apparel, Cleaning & Disinfection Products, Sterilization Consumables, Air Filtration Products, Other Consumables); By Application (Pharmaceutical & Biotechnology, Semiconductors & Electronics, Aerospace & Defense, Medical Devices, Other Applications); By End User (Pharmaceutical Companies, Semiconductor Manufacturers, Medical Device Manufacturers, Contract Manufacturing Organizations, Hospitals & Healthcare Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Cleanroom Consumables Market is projected to experience steady growth, with a CAGR of 7.8 % , valued at approximately USDRead More

Published Date: AUG-2025 | No Of Pages:187 | $ 4485

Pharmaceutical Filtration Market By Product Type (Membrane Filters, Depth Filters, Cartridge Filters, Syringe Filters, Capsule Filters, Filter Holders); By Technique (Microfiltration, Ultrafiltration, Nanofiltration, Crossflow, Vacuum Filtration); By Application (Final Product Processing, Raw Material Filtration, Cell Separation, Water Purification, Air/Gas Filtration); By End User (Pharmaceutical & Biopharmaceutical Companies, CMOs/CDMOs, Academic & Research Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Pharmaceutical Filtration Market is projected to reach USD 21.4 billion by 2030 , up from an estimated USD 11.9 billion in 2024 , growing at a steady <... Read More

Published Date: AUG-2025 | No Of Pages:191 | $ 4485

Janus Kinase (JAK) Inhibitors Market By Drug Type (Pan-JAK Inhibitors, Selective JAK Inhibitors); By Application (Rheumatology, Dermatology, Gastroenterology, Hematology & Oncology); By Route of Administration (Oral, Topical); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Janus Kinase (JAK) Inhibitors Market will witness a steady CAGR of 9.1% , valued at USD 18.7 billion in 2024 , and expected to grow to USD 31.2... Read More

Published Date: AUG-2025 | No Of Pages:195 | $ 4485

Hyperkalemia Treatment Market By Treatment Type (Potassium Binders, Diuretics & Others, Acute Rescue Therapies); By Disease Association (Chronic Kidney Disease, Heart Failure, Diabetes Mellitus); By Route of Administration (Oral, Intravenous); By End User (Hospitals, Outpatient Clinics, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Hyperkalemia Treatment Market is poised for a steady climb, projected to grow at a CAGR of 6.8% , with a market value of approximately USD 1.34 billion in 2024 , and ex... Read More

Published Date: AUG-2025 | No Of Pages:198 | $ 4485

Atherosclerosis Drugs Market By Drug Type (Statins, PCSK9 Inhibitors, Antiplatelet Drugs, Anti-inflammatory Drugs, Cholesterol Absorption Inhibitors); By Therapeutic Application (Primary Prevention, Secondary Prevention, Acute Treatment); By Region, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Atherosclerosis Drugs Market is poised for notable growth, with a projected compound annual growth rate (CAGR) of approximately 6.3% from 2024 to 2030, reaching an esti... Read More

Published Date: AUG-2025 | No Of Pages:193 | $ 4485

Viral Vector Manufacturing Market By Vector Type (Adenoviral, Adeno-Associated Viral [AAV], Lentiviral, Retroviral, Others); By Workflow Stage (Upstream Processing, Downstream Processing, Quality Control & Analytics); By Application (Gene Therapy, Cell Therapy, Vaccinology, Oncology Research, Infectious Disease Therapeutics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction and Strategic Context

The Global Viral Vector Manufacturing Market will witness a robust CAGR of 15.8%, valued at $1.85 billion in 2024, and is expected to appreciate significantly to reach $4.46 billion by 2030, confirms... Read More

Published Date: JUL-2025 | No Of Pages:181 | $ 4485

Therapeutic Drug Monitoring Market By Product Type (Consumables, Instruments, Software & Services); By Technology (Immunoassays, Chromatographic Techniques); By End User (Hospitals, Diagnostic Laboratories, Academic & Research Institutes, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global Therapeutic Drug Monitoring Market will witness a robust CAGR of 10.1% , valued at $2.16 billion in 2024 , expected to appreciate and reach $3.82 billion by 2030 , conf... Read More

Published Date: JUL-2025 | No Of Pages:194 | $ 4485

Protein Binding Assays Market By Product Type (Consumables, Instruments, Software & Services); By Technique (Equilibrium Dialysis, Ultrafiltration, Surface Plasmon Resonance, Others); By Application (Preclinical Drug Development, Clinical Pharmacokinetics, Toxicology, Biologics Profiling); By End User (Pharmaceutical & Biotechnology Companies, CROs, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Protein Binding Assays Market will witness a robust CAGR of 9.1% , valued at $630 million in 2024 , and is expected to appreciate and reach $1.06 billion by 2030 , conf... Read More

Published Date: JUL-2025 | No Of Pages:199 | $ 4485

Nuclear Magnetic Resonance Spectroscopy Market By Product Type (High-Resolution NMR, Benchtop NMR, Cryoprobes, Software); By Application (Drug Discovery, Metabolomics, Food Testing, Diagnostics); By End User (Pharma & Biotech, Academic Institutes, Hospitals, Testing Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global Nuclear Magnetic Resonance (NMR) Spectroscopy Market will witness a robust CAGR of 7.1% , valued at USD 1.32 billion in 2024 , and is expected to appreciate and reach USD 1.98 bill... Read More

Published Date: JUL-2025 | No Of Pages:165 | $ 4485

Tangential Flow Filtration Market By Product Type (Single-use Systems, Reusable Systems, Membrane Filters, Accessories); By Membrane Material (PES, Cellulose, PVDF, Others); By Application (Protein Purification, Vaccine Production, Antibody Production, Nucleic Acid Purification, Others); By End User (Biopharma Companies, CMOs/CROs, Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction and Strategic Context

The Global Tangential Flow Filtration Market will witness a robust CAGR of 11.8%, valued at $3.74 billion in 2024, expected to appreciate and reach $7.06 billion by 2030, confirms Strategic Market Research. This surge is fueled by escal... Read More

Published Date: JUL-2025 | No Of Pages:186 | $ 4485

Adeno-Associated Virus (AAV) Vector Manufacturing Market By Vector Type (Single-Stranded AAV, Self-Complementary AAV); By Application (Gene Therapy, Cell Therapy, Vaccinology, Research Use); By Manufacturing Platform (Plasmid Transfection, Baculovirus/Insect Cell System, HSV-Based System, Stable Producer Cell Lines); By End User (Biopharmaceutical & Biotechnology Companies, Academic & Research Institutions, CDMOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

1: Introduction and Strategic Context

The Global Adeno-Associated Virus (AAV) Vector Manufacturing Market will witness a robust CAGR of 17.6%, valued at $4.6 billion in 2024, and is expected to appreciate and reach $12.17 billion by 2030, confirms Strategic Market Res... Read More

Published Date: JUL-2025 | No Of Pages:163 | $ 4485

G-Protein Coupled Receptors (GPCRs) Market By Drug Class (Agonists, Antagonists, Inverse Agonists, Allosteric Modulators); By Therapeutic Area (Oncology, Cardiovascular, CNS, Metabolic, Immunology); By Molecule Type (Small Molecules, Biologics, Peptides); By End User (Pharma & Biotech, CROs, Academic, Diagnostics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global G - Protein Coupled Receptors ( Gpcrs ) Market will witness a robust CAGR of 6.9% , valued at approx... Read More

Published Date: JUL-2025 | No Of Pages:191 | $ 4485

DNA Repair Drugs Market By Drug Class (PARP Inhibitors, ATM/ATR Inhibitors, DNA-PK Inhibitors, CHK1/CHK2 Inhibitors, Others); By Application (Breast Cancer, Ovarian Cancer, Prostate Cancer, Pancreatic Cancer, Others); By End User (Hospitals, Specialty Cancer Centers, Academic & Research Institutes, Retail & Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global DNA Repair Drugs Market will witness a robust CAGR of 11.4% , valued at $5.6 billion in 2024 , expected to appreciate and reach $10.7 billion by 2... Read More

Published Date: JUL-2025 | No Of Pages:191 | $ 4485

Recombinant Cell Culture Supplements Market By Product Type (Recombinant Albumin, Recombinant Insulin, Recombinant Transferrin, Recombinant Growth Factors, Others); By Application (Biopharmaceutical Production, Stem Cell Therapy, Gene Therapy, Vaccine Manufacturing, R&D); By End User (Biopharmaceutical Companies, CDMOs, Academic & Research Institutes, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global Recombinant Cell Culture Supplements Market will witness a robust CAGR of 11.7% , valued at $468.2 million in 2024 , and is expected to appreciate and reach approximately $890.4 million by 2030 , confirms Strategic Market Research<... Read More

Published Date: JUL-2025 | No Of Pages:165 | $ 4485

Interventional Oncology Market By Product Type (Ablation Devices, Embolization Devices, Supportive Products); By Procedure Type (Thermal Ablation, Non-Thermal Ablation, Embolization); By Cancer Type (Liver, Lung, Kidney, Bone & Others); By End User (Hospitals, Clinics, Academic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Interventional Oncology Market will witness a robust CAGR of 7.5%, valued at $3.85 billion in 2024, expected to appreciate and reach $5.94 billion by 2030, confirms Strategic Market Research.

Interventional on... Read More

Published Date: JUL-2025 | No Of Pages:193 | $ 4485

Erectile Dysfunction Drugs Market By Drug Type (PDE5 Inhibitors, Hormone-Based Therapies, Alprostadil, Herbal & Others); By Route of Administration (Oral, Injectable, Topical, Sublingual, Intranasal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction and Strategic Context

The Global Erectile Dysfunction Drugs Market will witness a steady CAGR of 5.6%, valued at USD 3.75 billion in 2024, and is expected to appreciate and reach USD 5.18 billion by 2030, confirms Strategic Market Research.

&nbs... Read More

Published Date: JUL-2025 | No Of Pages:150 | $ 4485

U.S. ADHD Controlled Substances Market By Drug Class (Amphetamine-Based Stimulants, Methylphenidate-Based Stimulants); By Age Group (Pediatric, Adolescent, Adult); By Distribution Channel (Retail Pharmacies, Online and Mail-Order Pharmacies, Institutional and Closed-Door Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

TABLE OF CONTENTS
PART I: MARKET INTELLIGENCE FRAMEWORK AND STRATEGIC CONTEXT
1.    RESEARCH FRAMEWORK AND MARKET SCOPE ALIGNMENT
1.1. Defining the Research Scope
1.1.1. ADHD Therapeutic Overview and Market Boundaries
1.1.2. Focus on Schedule II Contro... Read More

Published Date: JUL-2025 | No Of Pages:150 | $ 1500

Topical Drugs CDMO Market By Service Type (Formulation Development and Preclinical Services, Commercial Manufacturing, Analytical and Regulatory Support); By Product Type (Creams and Ointments, Gels and Lotions, Transdermal Patches, Foams and Sprays); By Therapeutic Application (Dermatological Disorders, Pain Management, Hormone Replacement and Oncology, Aesthetic Dermatology and Cosmeceuticals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction and Strategic Context

The Global Topical Drugs CDMO Market represents a vital segment of the broader pharmaceutical outsourcing industry, encompassing the contract development and manufacturing of dermatological, transdermal, and mucosal drug formulations... Read More

Published Date: JUL-2025 | No Of Pages:150 | $ 4485

Drug Abuse Testing Market By Product Type (Analytical Instruments, Rapid Testing Devices, Consumables); By Sample Type (Urine, Blood, Oral Fluid, Hair, Sweat); By End User (Hospitals & Labs, Workplace, Law Enforcement, Education, Home Users); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction and Strategic Context

The Global Drug Abuse Testing Market will witness a robust CAGR of 6.8%, valued at $6.4 billion in 2024, and is expected to appreciate and reach $9.5 billion by 2030, confirms Strategic Market Research.

Drug abus... Read More

Published Date: Jul-2025 | No Of Pages:150 | $ 4485

Multiplex Assays Market By Product Type (Nucleic Acid Assays, Protein Assays, Cell-Based Assays, Others); By Application (Clinical Diagnostics, Research and Development, Drug Discovery and Development, Others); By End-User (Hospitals and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Research and Academic Institutes); By Geography, Segment revenue estimation, Forecast, 2023-2030

Industry Report and Statistics (Facts & Figures) - Sales Volume & ASP by Product Type & Technology

 

The global multiplex assays market will witness a robust CAGR of 11.2%, valued at $2.5 billion in 2022, and expect... Read More

Published Date: Mar-2022 | No Of Pages:135 | $ 4485